Check if trademark ACCELERATING PRECISION MEDICINE is available

USPTO Filing History

Key events recorded for this trademark application

2020-08-26 — Application filed
2020-08-29 — Application filed
2020-09-30 — Application filed
2020-11-24 — Assigned to examiner
2020-11-24 — Examiners amendment -written
2020-11-24 — Examiners amendment e-mailed
2020-11-24 — Notification of examiners amendment e-mailed
2020-11-24 — Examiner's amendment entered
2020-11-24 — Suspension letter written
2020-11-24 — Letter of suspension e-mailed
2020-11-24 — Notification of letter of suspension e-mailed
2021-08-11 — Teas change of owner address received
2021-08-11 — Teas revoke/app/change addr of atty/dom rep received
2021-08-11 — Attorney/dom.rep.revoked and/or appointed
2021-08-11 — Teas change of correspondence received
2021-08-11 — Applicant/correspondence changes (non-responsive) entered
2021-08-18 — Suspension checked - to attorney for action
2021-08-19 — Suspension inquiry written
2021-08-19 — Inquiry to suspension e-mailed
2021-08-19 — Notification of inquiry as to suspension e-mailed
2021-10-22 — Teas response to suspension inquiry received
2021-10-28 — Assigned to lie
2021-10-29 — Correspondence received in law office
2021-10-29 — Teas/email correspondence entered
2021-10-29 — Suspension letter written
2021-10-29 — Letter of suspension e-mailed
2021-10-29 — Notification of letter of suspension e-mailed
2022-06-01 — Suspension checked - to attorney for action
2022-06-06 — Suspension inquiry written
2022-06-06 — Inquiry to suspension e-mailed
2022-06-06 — Notification of inquiry as to suspension e-mailed
2022-06-07 — Teas revoke/app/change addr of atty/dom rep received
2022-06-07 — Attorney/dom.rep.revoked and/or appointed
2022-06-07 — Teas change of correspondence received
2022-12-05 — Teas response to suspension inquiry received
2022-12-05 — Applicant/correspondence changes (non-responsive) entered
2022-12-05 — Correspondence received in law office
2022-12-05 — Teas/email correspondence entered
2022-12-06 — Suspension letter written
2022-12-06 — Letter of suspension e-mailed
2022-12-06 — Notification of letter of suspension e-mailed
2023-06-05 — Suspension inquiry written
2023-06-05 — Inquiry to suspension e-mailed
2023-06-05 — Notification of inquiry as to suspension e-mailed
2023-09-04 — Teas response to suspension inquiry received
2023-09-06 — Correspondence received in law office
2023-09-06 — Teas/email correspondence entered
2023-09-06 — Suspension letter written
2023-09-06 — Letter of suspension e-mailed
2023-09-06 — Notification of letter of suspension e-mailed
2024-03-05 — Suspension inquiry written
2024-03-05 — Inquiry to suspension e-mailed
2024-03-05 — Notification of inquiry as to suspension e-mailed
2024-03-12 — Teas revoke/app/change addr of atty/dom rep received
2024-03-12 — Attorney/dom.rep.revoked and/or appointed
2024-03-12 — Teas change of domestic representatives address
2024-03-12 — Teas change of correspondence received
2024-04-09 — Teas response to suspension inquiry received
2024-04-10 — Applicant/correspondence changes (non-responsive) entered
2024-04-10 — Correspondence received in law office
2024-04-10 — Teas/email correspondence entered
2024-04-10 — Letter of suspension e-mailed
2024-04-10 — Notification of letter of suspension e-mailed
2024-04-10 — Suspension letter written
2025-01-03 — Suspension inquiry written
2025-01-03 — Notification of inquiry as to suspension e-mailed
2025-01-03 — Inquiry to suspension e-mailed
2025-04-21 — Application abandoned
2025-04-21 — Application abandoned
2025-04-21 — Final status recorded

Owner Information

Point Biopharma Corp.
Toronto, Ontario CA

Correspondent

John R. Rudolph Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285
UNITED STATES

Filing Details

Filing Date:
2020-08-26

Status Date:
2025-04-21

Category:
Pharmaceuticals

Filing Year:
2020